Back to JNJ Stock Lookup

JNJ Related FDA

May 13, 2013 08:04 AM J&J's (JNJ) Janssen Receives Priority Review from FDA for Simeprevir
Apr 1, 2013 11:47 AM Amarin's (AMRN) Vascepa Tracking Well 3-Months In; Investors Eye Tier 2 Designation
Mar 7, 2013 08:12 AM Janssen-Cilag (JNJ) Submits MA to EMA for Canagliflozin, Metformin in Type 2 Diabetes
Jan 28, 2013 07:01 AM Idenix (IDIX) Enters Collaboration with Janssen Pharma for DAA HCV Evaluatlion
Dec 31, 2012 09:17 AM FDA Grants Accelerated Approval for SIRTURO (bedaquiline) For Pulmonary MDR-TB
Dec 12, 2012 09:05 AM Janssen (JNJ) Submits NDA for Canagliflozin to FDA
Dec 10, 2012 01:41 PM Janssen Approved for Expanded Indication of ZYTIGA (JNJ)
Dec 10, 2012 01:18 PM FDA Said to Approve Expanded Indication for Janssen's (JNJ) Zytiga
Nov 28, 2012 05:47 PM J&J's (JNJ) Janssen Receives FDA Panel Backing for MDR-TB Drug Bedaquiline
Nov 28, 2012 05:19 PM J&J's (JNJ) Experimental TB Drug Receives Unanimous FDA Panel Backing
Nov 19, 2012 07:27 AM J&J's (JNJ) Janssen Receives Position EMA CHMP Opinion for ZYTIGA as mCRPC Treatment
Nov 12, 2012 08:23 AM J&J's (JNJ) Janssen Reports Significant Phase 3 Data from Golimumab on Radiographic Progression in RA Patients
Nov 12, 2012 08:10 AM J&J's (JNJ) Janssen Reports Significant Findings from PSUMMIT II on Psoriatic Arthritis
Nov 1, 2012 10:36 AM Vertex (VRTX) Pops Higher, Enters Two New HCV Treatment Collaborations
Oct 16, 2012 06:28 AM J&J (JNJ) to Present New TMC435 Data on HCV at AASLD in Nov.
Sep 28, 2012 06:18 AM J&J's (JNJ) Janssen-Cilag Gets EC Approval for DACOGEN in AML
Sep 21, 2012 08:38 AM Alzheimer's Treatment Pharmas on Watch as Merz Gets Positive CHMP Opinion for Memantine MAA
Sep 18, 2012 05:03 PM J&J's (JNJ) Janssen Unit Submits BLA for Anti-TNF)-alpha SIMPONI
Sep 10, 2012 10:55 AM Johnson & Johnson (JNJ) Said to Settle Risperdal Case on First Day; Shares Move Higher
Sep 5, 2012 07:34 AM Johnson & Johnson's (JNJ) Janssen Granted Priority Review for TMC207 NDA
Sep 4, 2012 10:51 AM Leerink Swann Maintains an 'Outperform' on Medivation (MDVN); Number of Advantages Based on Labeling
Aug 30, 2012 12:05 PM J&J's (JNJ) Janssen Settles RISPERDAL Suit w/ 36 States and D.C.; Will Pay $181M
Aug 29, 2012 08:30 AM Janssen Pharmaceuticals (JNJ) Receives sNDA for NUCYNTA ER for Pain Associated with Diabetic Peripheral Neuropathy
Aug 29, 2012 08:19 AM Janssen (JNJ) Receives FDA Priority View for sNDA of ZYTIGA
Aug 29, 2012 08:18 AM Janssen Says ZYTIGA sNDA Received Priority Review Status from FDA (JNJ)
Aug 6, 2012 05:44 PM Elan (ELN) Updates Investors on Bapineuzumab Discontinuation
Aug 6, 2012 05:07 PM Johnson & Johnson (JNJ) Says Bapineuzumab IV in Alzheimer's Stopped
Jul 25, 2012 12:52 PM Canaccord Genuity Afternoon Coffee on PFE, ELN, and JNJ: I Just Forgot What I Was About to Say
Jun 5, 2012 09:25 AM Janssen, Johnson & Johnson (JNJ) to Present Data from Five Pivotal Canagliflozin Phase 3s
May 29, 2012 09:13 AM J&J (JNJ) Says FDA Issued CRL for Janssen's 800mg PREZISTA
Apr 11, 2012 10:56 AM J&J (JNJ) subject of $1.1 billion penalty in Risperdal trial in Arkansas
Mar 12, 2012 10:44 AM Canaccord Genuity Morning Coffee on Dendreon (DNDN) and Johnson & Johnson (JNJ): Honeydew Sized Prostate
Mar 8, 2012 08:42 AM Medivation (MDVN) Higher on Positive Data from J&J's Zytiga
Mar 8, 2012 08:42 AM Committee Recommends J&J's (JNJ) ZYTIGA Study Be Unblinded Amid Better Survival Data
Mar 8, 2012 08:40 AM Dendreon (DNDN) Smacked on Positive Data from J&J's (JNJ) Zytiga
Jan 23, 2012 08:32 AM Boston Scientific (BSX) Gets Favorable Ruling in Patent Case with J&J (JNJ)
Jan 5, 2012 02:51 PM Johnson & Johnson (JNJ) said to agree to $1 billion accord in Risperdal sales probe
Jan 4, 2012 03:02 PM J&J (JNJ), CR Bard (BCR) Ordered to Study Injuries from Vaginal Implants -Bloomberg
Dec 9, 2011 03:16 PM FDA Panel Says Benefits of J&J (JNJ) Birth Control Patch Outweigh Risks -Bloomberg
Dec 8, 2011 04:10 PM Pharmacyclics (PCYC) Enters PCI-32765 Collaboration w/ J&J (JNJ) Unit; to Get $150M Upfront
Nov 29, 2011 06:46 AM ImmunoGen (IMGN) to Discontinue IMGN388 Development, Will Refocus Resources
Nov 9, 2011 07:51 AM Affymax (AFFY) Settles with J&Js (JNJ) Janssen Biotech; Will Pay $13M in Fees, Milestones
Oct 21, 2011 11:16 AM EC Opens Investigation on J&J (JNJ) Over Fentanyl Patches (NVS)
Sep 29, 2011 06:56 AM Boston Scientific's (BSX) NIR Stent Found Not to Infringe on J&J's (JNJ) Fischell Patent
Sep 8, 2011 05:13 PM Johnson & Johnson (JNJ), Bayer Receive Favorable FDA Panel Vote for Xarelto
Sep 6, 2011 09:34 AM Johnson & Johnson (JNJ), Bayer Lower after Receiving Adverse Comments About Blood-Thinner, Xarelto
Aug 19, 2011 02:17 PM J&J's (JNJ) Depuy Orthopaedics Gets FDA 501k Clearance to Trumatch
May 20, 2011 10:22 AM J&J's (JNJ) Cordis Receives FDA Approval for Exoseal(TM) Vascular Closure Device
Apr 28, 2011 02:48 PM FDA Approves J&J's (JNJ) Zytiga; Dendreon (DNDN) Shares Volatile Following Announcement
Apr 15, 2011 07:07 AM Merck (MRK) Settles with J&J (JNJ); to Make One-Time Payment of $500M; Affirms FY11 Outlook

Back to JNJ Stock Lookup